Poj Lysouvakon to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Poj Lysouvakon has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.034
-
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists. Hosp Pediatr. 2024 03 01; 14(3):e170-e172.
Score: 0.034